Get the Stockscreener App
0.6285
6.19%
-0.0415
After Hours:
.63
0.0015
+0.24%
Mainz Biomed N.V. Stock (MYNZ) Forecast
The Mainz Biomed N.V. (MYNZ) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.837, representing a +33.17% increase from the current price of $0.6285. The highest analyst price target is $1.652, and the lowest is $0.022.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MYNZ Price Target
Average 10.70
(+1,603% Upside)
Is Mainz Biomed N.V. (MYNZ) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.69 | Buy |
| STOCH(9,6) | 10.98 | Buy |
| STOCHRSI(14) | 13.49 | Buy |
| MACD(12,26) | -0.0834 | Sell |
| ADX(14) | 25.53 | Sell |
| William %R | -94.06 | Buy |
| CCI(14) | -126.00 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7114
Sell
|
0.714
Sell
|
| MA20 |
0.7957
Sell
|
0.7829
Sell
|
| MA50 |
0.9328
Sell
|
0.8973
Sell
|
| MA100 |
0.9901
Sell
|
1.141
Sell
|
| MA200 |
1.7496
Sell
|
2.0018
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MYNZ could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on MYNZ, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.69 indicates that MYNZ is oversold. This indicates that MYNZ price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 10.98 indicates that MYNZ is oversold. This indicates that MYNZ price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.49 indicates that MYNZ is oversold. This suggests that MYNZ price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.53 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -126 indicates that MYNZ is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MYNZ price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mainz Biomed N.V. financial reports and earnings history, Mainz Biomed N.V. (MYNZ) stock could reach $17.64 by 2030, $23.45 by 2040 and $82.39 by 2050. See the projected annual prices until 2050 of the Mainz Biomed N.V. stock below:
- Mainz Biomed N.V. (MYNZ) is expected to reach an average price of $8.2541 in 2035, with a high prediction of $8.5629 and a low estimate of $8.3541. This indicates an $1,213% rise from the last recorded price of $0.6285.
- Mainz Biomed N.V. (MYNZ) stock is projected to chart a bullish course in 2040, with an average price target of $23.06, representing an $3,569% surge from its current level. The forecast ranges from a conservative $23.06 to a sky-high $23.45.
- Our analysts predict Mainz Biomed N.V. (MYNZ) to jump 7,425% by 2045, soaring from $47.29 to an average price of $47.29, potentially reaching $46.80. While $47.29 is the low estimate, the potential upside is significant.
- Mainz Biomed N.V. (MYNZ) stock is expected to climb by 2050, reaching an average of $82.13, a $12,967% jump from its current level. However, a wide range of estimates exists, with high and low targets of $82.39 and $6.0254, respectively, highlighting the market's uncertainty.
Mainz Biomed N.V. Stock (MYNZ) Year by Year Forecast
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2024
Our forecast for MYNZ stock price in 2024 now indicates an average price target of $10.70 with a high forecast of $21.38 and a low forecast of $0.022. The average prediction reflects an increase of +1,603% from the last recorded price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.592 | $0.022 | $1.652 | +153.30% |
| July, 2024 | $6.9891 | $1.2594 | $21.38 | +1,012% |
| August, 2024 | $7.5388 | $3.7501 | $10.30 | +1,099% |
| September, 2024 | $5.7485 | $2.7985 | $6.9862 | +814.64% |
| October, 2024 | $6.6556 | $4.9559 | $9.8233 | +958.97% |
| November, 2024 | $4.6153 | $4.2853 | $7.223 | +634.34% |
| December, 2024 | $4.215 | $2.0527 | $4.9876 | +570.65% |
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2025
Mainz Biomed N.V. Stock (MYNZ) is expected to reach an average price of $2.5629 in 2025, with a high prediction of $5.1144 and a low estimate of $0.0115. This indicates an +307.79% rise from the last recorded price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.1821 | $1.3773 | $4.6299 | +247.20% |
| February, 2025 | $3.2018 | $2.077 | $5.1144 | +409.44% |
| March, 2025 | $2.6515 | $2.4491 | $4.5615 | +321.88% |
| April, 2025 | $2.5786 | $1.299 | $3.259 | +310.29% |
| May, 2025 | $0.9183 | $0.0309 | $2.636 | +46.12% |
| June, 2025 | $1.178 | $0.2658 | $1.638 | +87.44% |
| July, 2025 | $2.6952 | $0.8955 | $3.8664 | +328.83% |
| August, 2025 | $1.7549 | $1.0608 | $3.4342 | +179.21% |
| September, 2025 | $1.4446 | $0.9423 | $2.6771 | +129.84% |
| October, 2025 | $1.9617 | $1.442 | $2.6143 | +212.12% |
| November, 2025 | $2.0014 | $0.8214 | $2.719 | +218.44% |
| December, 2025 | $0.1285 | $0.0115 | $2.2162 | -79.55% |
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2026
The predicted value for Mainz Biomed N.V. (MYNZ) in 2026 is set at an average of $1.0549. Estimates vary from a peak of $2.0905 to a trough of $0.0193, indicating an +67.84% surge from the present price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9282 | $0.4208 | $1.6534 | +47.69% |
| February, 2026 | $1.1479 | $0.7357 | $2.0905 | +82.64% |
| March, 2026 | $0.9276 | $0.6628 | $1.4053 | +47.59% |
| April, 2026 | $0.4847 | $0.4547 | $1.445 | -22.88% |
| May, 2026 | $0.0456 | $0.0279 | $0.7221 | -92.75% |
| June, 2026 | $0.2541 | $0.0193 | $1.4467 | -59.57% |
| July, 2026 | $0.5988 | $0.071 | $0.5415 | -4.73% |
| August, 2026 | $1.1491 | $0.1865 | $0.9991 | +82.83% |
| September, 2026 | $1.0319 | $1.0568 | $1.0542 | +64.19% |
| October, 2026 | $0.6472 | $0.7822 | $0.7297 | +2.98% |
| November, 2026 | $0.7375 | $0.72 | $0.6324 | +17.35% |
| December, 2026 | $0.3944 | $0.4708 | $0.4277 | -37.24% |
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mainz Biomed N.V. (MYNZ) is $6.3871, with a high forecast of $12.76 and a low forecast of $0.0109. This indicates an +916.25% increase from the last price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0657 | $0.1437 | $0.238 | -89.54% |
| February, 2027 | $0.0479 | $0.0109 | $0.214 | -92.37% |
| March, 2027 | $8.4203 | $0.016 | $8.39 | +1,240% |
| April, 2027 | $8.7609 | $8.8705 | $8.1406 | +1,294% |
| May, 2027 | $3.5185 | $4.2014 | $7.1961 | +459.82% |
| June, 2027 | $1.5673 | $1.757 | $12.76 | +149.37% |
| July, 2027 | $3.9779 | $2.4127 | $1.965 | +532.91% |
| August, 2027 | $1.2285 | $1.6485 | $1.8367 | +95.46% |
| September, 2027 | $2.8442 | $1.0836 | $1.0842 | +352.54% |
| October, 2027 | $2.9648 | $3.2994 | $2.8545 | +371.73% |
| November, 2027 | $5.3809 | $3.41 | $3.7054 | +756.16% |
| December, 2027 | $4.3912 | $4.7209 | $4.6209 | +598.68% |
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2028
In 2028, Mainz Biomed N.V. (MYNZ) is projected to reach an average price of $3.5112, with a high projection of $4.7034 and a low estimate of $2.319. This indicates an +458.67% rise from the last price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.1518 | $3.9466 | $3.6115 | +560.59% |
| February, 2028 | $4.0824 | $4.0569 | $3.8824 | +549.55% |
| March, 2028 | $5.9382 | $4.2727 | $4.6182 | +844.81% |
| April, 2028 | $4.7388 | $4.9388 | $4.7034 | +653.98% |
| May, 2028 | $2.4925 | $3.0194 | $4.2239 | +296.58% |
| June, 2028 | $3.6351 | $3.1197 | $2.905 | +478.38% |
| July, 2028 | $3.3457 | $3.8657 | $3.3606 | +432.33% |
| August, 2028 | $2.8205 | $3.1715 | $3.0912 | +348.76% |
| September, 2028 | $2.6921 | $2.6669 | $2.4366 | +328.33% |
| October, 2028 | $2.3627 | $2.7527 | $2.4924 | +275.92% |
| November, 2028 | $3.0884 | $3.1178 | $4.1681 | +391.40% |
| December, 2028 | $2.029 | $2.319 | $2.6687 | +222.84% |
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2029
The 2029 price forecast for Mainz Biomed N.V. Stock (MYNZ) is $2.1625 on average, with a high prediction of $3.3581 and a low estimate of $0.9669. This represents an +244.07% increase from the previous price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6948 | $2.7953 | $2.4745 | +328.77% |
| February, 2029 | $2.5154 | $2.5654 | $2.3003 | +300.22% |
| March, 2029 | $3.216 | $2.8806 | $2.7909 | +411.70% |
| April, 2029 | $2.3266 | $2.6666 | $2.8613 | +270.18% |
| May, 2029 | $2.8424 | $2.7369 | $2.5774 | +352.25% |
| June, 2029 | $2.593 | $2.603 | $2.9527 | +312.56% |
| July, 2029 | $3.0536 | $3.2436 | $3.3581 | +385.85% |
| August, 2029 | $2.6793 | $2.7493 | $3.0339 | +326.31% |
| September, 2029 | $2.3699 | $2.3899 | $2.4645 | +277.08% |
| October, 2029 | $1.8815 | $1.8847 | $2.2351 | +199.36% |
| November, 2029 | $1.2763 | $1.3263 | $1.7198 | +103.07% |
| December, 2029 | $0.9419 | $0.9669 | $1.1264 | +49.86% |
Mainz Biomed N.V. Stock (MYNZ) Price Forecast for 2030
Mainz Biomed N.V. Stock (MYNZ) is expected to reach an average price of $9.2036 in 2030, with a high forecast of $17.64 and a low forecast of $0.7671. This signifies an +1,364% surge from the last price of $0.6285.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.78 | $0.7671 | $17.64 | +2,729% |
| February, 2030 | $16.96 | $17.95 | $17.19 | +2,598% |
| March, 2030 | $12.30 | $16.10 | $16.41 | +1,857% |
| April, 2030 | $9.7904 | $3.8136 | $9.4604 | +1,458% |
| May, 2030 | $10.40 | $10.63 | $9.6791 | +1,555% |
| June, 2030 | $9.40 | $9.87 | $9.7568 | +1,396% |
| July, 2030 | $10.25 | $8.9554 | $8.2986 | +1,531% |
| August, 2030 | $10.16 | $10.87 | $10.38 | +1,516% |
| September, 2030 | $10.76 | $10.76 | $10.37 | +1,612% |
| October, 2030 | $10.41 | $11.73 | $11.63 | +1,557% |
| November, 2030 | $10.37 | $10.67 | $10.41 | +1,550% |
| December, 2030 | $10.70 | $10.67 | $10.24 | +1,603% |
0.39%
Cap:
|
Volume (24h):